Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Get Free Report)’s stock price passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $23.37 and traded as low as $22.93. Invesco Nasdaq Biotechnology ETF shares last traded at $22.93, with a volume of 8,966 shares trading hands.
Invesco Nasdaq Biotechnology ETF Price Performance
The stock has a market capitalization of $37.38 million, a price-to-earnings ratio of 17.39 and a beta of 0.61. The firm has a 50 day simple moving average of $23.57 and a 200-day simple moving average of $23.38.
Invesco Nasdaq Biotechnology ETF Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, September 27th. Stockholders of record on Monday, September 23rd were issued a $0.089 dividend. This is an increase from Invesco Nasdaq Biotechnology ETF’s previous quarterly dividend of $0.05. This represents a $0.36 annualized dividend and a dividend yield of 1.55%. The ex-dividend date of this dividend was Monday, September 23rd.
Hedge Funds Weigh In On Invesco Nasdaq Biotechnology ETF
About Invesco Nasdaq Biotechnology ETF
The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.
Featured Stories
- Five stocks we like better than Invesco Nasdaq Biotechnology ETF
- Dividend Capture Strategy: What You Need to Know
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- 5 discounted opportunities for dividend growth investors
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.